Wednesday, July 8, 2026

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

ASSEMBLY BIOSCIENCES clinical programs — 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Intelligence · Clinical Programs

ASSEMBLY BIOSCIENCES projects

15 ClinicalTrials.gov programs sponsored by ASSEMBLY BIOSCIENCES.

ASSEMBLY BIOSCIENCES has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ABI-H0731

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    6 trials
  2. VBR

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial
  3. standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI)

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 2 small molecule terminated

    1 trial
  4. ABI-1179

    ASSEMBLY BIOSCIENCES, INC.

    Recurrent Genital Herpes Simplex Type 2

    phase 1 small molecule completed

    1 trial
  5. ABI-4334

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial
  6. ABI-4334 Tablet

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial
  7. ABI-4334-102

    ASSEMBLY BIOSCIENCES, INC.

    chronic hepatitis B virus infection (cHBV)

    phase 1 other active

    1 trial
  8. ABI-5366

    ASSEMBLY BIOSCIENCES, INC.

    Recurrent Genital Herpes Simplex Type 2

    phase 1 small molecule completed

    1 trial
  9. ABI-6250

    ASSEMBLY BIOSCIENCES, INC.

    Hepatitis Delta Virus

    phase 1 small molecule completed

    1 trial
  10. ABI-H2158

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    3 trials
  11. ABI-H2158 Reference Formulation

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial
  12. ABI-H3733

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial
  13. ABI-H3733 Liquid Oral Dosage Form

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial
  14. ABI-M201

    ASSEMBLY BIOSCIENCES, INC.

    Ulcerative Colitis Chronic Mild

    phase 1 small molecule terminated

    1 trial
  15. Vebicorvir (VBR)

    ASSEMBLY BIOSCIENCES, INC.

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does ASSEMBLY BIOSCIENCES have?

15 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.